Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Fay

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Progress in Clinical and Biological Research|January 1, 1990
Elimination of chemoresistant myeloma clonogenic cells from human bone marrow by monoclonal antibody and complementA W Tong, W S Dalton, T Tsuruo, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Elimination of leukemic cells by laser photodynamic therapyK S Gulliya, J W Fay, R M Dowben, et al.
Blood|November 1, 1981
Phenotypic characterization of human bone marrow granulocyte-macrophage forming progenitor cellsM N Levine, J W Fay, N H Jones, et al.
Experimental Hematology|January 1, 1979
Autologous marrow transplantation for patients with acute myelogenous leukemia--a preliminary reportJ W Fay, H R Silberman, J O Moore, et al.
Bone Marrow Transplantation|October 11, 1992
Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppressionR H Collins, Z R Rogers, M Bennett, et al.
Seminars in Oncology|April 1, 1996
Dose-intensive chemotherapy with etoposide-cyclophosphamide for advanced breast cancer. North American Marrow Transplant GroupR H Herzig, J Lynch, N P Christiansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphomaG L Phillips, R H Herzig, H M Lazarus, et al.
Cancer Research|September 1, 1989
Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibodyA W Tong, J Lee, R M Wang, et al.
Human Immunology|May 1, 1994
Characterization of skin-infiltrating cells during acute graft-versus-host disease following bone marrow transplantation using unrelated marrow donorsA Nikaein, T Poole, R Fishbeck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 17, 1999
Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantationD Przepiorka, R A Nash, J R Wingard, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Progress in Clinical and Biological Research|January 1, 1990
Elimination of chemoresistant myeloma clonogenic cells from human bone marrow by monoclonal antibody and complementA W Tong, W S Dalton, T Tsuruo, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Elimination of leukemic cells by laser photodynamic therapyK S Gulliya, J W Fay, R M Dowben, et al.
Blood|November 1, 1981
Phenotypic characterization of human bone marrow granulocyte-macrophage forming progenitor cellsM N Levine, J W Fay, N H Jones, et al.
Experimental Hematology|January 1, 1979
Autologous marrow transplantation for patients with acute myelogenous leukemia--a preliminary reportJ W Fay, H R Silberman, J O Moore, et al.
Bone Marrow Transplantation|October 11, 1992
Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppressionR H Collins, Z R Rogers, M Bennett, et al.
Seminars in Oncology|April 1, 1996
Dose-intensive chemotherapy with etoposide-cyclophosphamide for advanced breast cancer. North American Marrow Transplant GroupR H Herzig, J Lynch, N P Christiansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphomaG L Phillips, R H Herzig, H M Lazarus, et al.
Cancer Research|September 1, 1989
Elimination of chemoresistant multiple myeloma clonogenic colony-forming cells by combined treatment with a plasma cell-reactive monoclonal antibody and a P-glycoprotein-reactive monoclonal antibodyA W Tong, J Lee, R M Wang, et al.
Human Immunology|May 1, 1994
Characterization of skin-infiltrating cells during acute graft-versus-host disease following bone marrow transplantation using unrelated marrow donorsA Nikaein, T Poole, R Fishbeck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 17, 1999
Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantationD Przepiorka, R A Nash, J R Wingard, et al.
Pageof 6